A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 26, Issue 2, 2012, Pages 101-108

  Lassman, Michael E ^a   McLaughlin, Theresa M ^a   Somers, Elizabeth P ^a   Stefanni, Alice C ^a   Chen, Zhu ^a   Murphy, Beth Ann ^a   Bierilo, Kathleen K ^a   Flattery, Amy M ^a   Wong, Kenneth K ^a   Castro Perez, Jose M ^a   Hubbard, Brian K ^a   Roddy, Thomas P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEINS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

APOLIPOPROTEINS; CROSS-SPECIES; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN PARTICLES; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LOW DENSITY LIPOPROTEINS; PROTEIN COMPONENTS; RAPID METHOD; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

PEPTIDES;

EID: 83755219552     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5296     Document Type: Article

References (24)

1. R. Ross,. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362, 801.
2. L. Chan,. Apolipoprotein-B, The major protein-component of triglyceride-rich and low-density lipoproteins. J. Biol. Chem. 1992, 267, 25621.
3. D. Rader,. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 2006, 116, 3090.
4. M.J. Callow, L.J. Stoltzfus, R.M. Lawn, E.M. Rubin,. Expression of human apolipoprotein-B and assembly of lipoprotein (a) in transgenic mice. Proc. Natl. Acad. Sci. 1994, 91, 2130.
5. R.E. Moore, M. Navab, J.S. Millar, F. Zimetti, S. Hama, G.H. Rothblat, D.J. Rader,. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ. Res. 2005, 97, 763.
6. A. Overgaar, H. Hanse, M. Lajer, L. Pedersen, L. Tarnow, P. Rossing, J.N. McGuire, F. Pociot,. Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy. Proteome Sci. 2010, 8, 4.
7. Q. Su, A. Rutledge, M. Dekker, K. Adeli,. Apolipoprotein B: not just a biomarker but a causal factor in hepatic endoplasmic reticulum stress and insulin resistance. Clin. Lipidol. 2010, 5, 267.
8. A.T. Nguyen, S. Braschi, M. Geoffrion, L.G. Fong, R.M. Crooke, M.J. Graham, S.G. Young, R. Milne,. A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing "apoB39-only" mice with mouse apoB48. Biochim. Biophys. Acta 2006, 1761, 182.
9. D.M. Levine, K.J. Williams,. Automated measurement of mouse apolipoprotein B: convenient screening tool for mouse model of atherosclerosis. Clin. Chem. 1997, 43, 669.
10. A.N. Hoofnagle, M.H. Wener,. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Methods 2009, 347, 3.
11. L. Anderson, C. Hunter,. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2005, 5, 573.
12. T.A. Addona, S.E. Abbatiello, B. Schilling, et al., Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27, 633.
13. M.A. Kuzyk, D. Smith, J. Yang, T.J. Cross, A.M. Jackson, D.B. Hardie, N.L. Anderson, C.H. Borchers,. MRM-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 2009, 8, 1860.
14. S.E. Ong, M. Mann,. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005, 1, 252.
15. V. Brun, C. Masselon, J. Garin, A. Dupuis,. Isotope dilution strategies for absolute quantitative proteomics. J. Proteomics 2009, 72, 740.
16. J.R. Barr, V.L. Maggio, D.G. Patterson, G.R. Cooper, L.O. Henderson, W.E. Turner, S.J. Smith, W.H. Hannon, L.L. Needham, E.J. Sampson,. Isotope dilution mass spectrometric quantification of specific proteins: Model application with apolipoprotein A-1. Clin. Chem. 1996, 42, 1676.
17. J.R. Whiteaker, L. Zhao, L. Anderson, A.G. Paulovich,. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteomics 2010, 9, 184.
18. C. Ji, N. Sadagopan, Y. Zhang, C. Lepsy,. A universal strategy for development of a method for absolute quantification of therapeutic monoclonal antibodies in biological matrices using differential dimethyl labeling coupled with ultra-performance liquid chromatography-tandem mass spectrometry. Anal. Chem. 2009, 81, 9321.
19. R.G. Kay, B. Gregory, P.G. Grace, S. Pleasance,. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun. Mass Spectrom. 2007, 21, 2585.
20. S.A. Agger, L.C. Marney, N.A. Hoofnagle,. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. Clin. Chem. 2010, 56, 1804.
21. R. Craig, J.P. Cortens, R.C. Beavis,. An open source system for analyzing, validating, and storing protein identification data. J. Proteome Res. 2004, 3, 1234.
22. Y. Lin, J. Zhou, D. Bi, P. Chen, X. Wang, S. Liang,. Sodium-deoxycholate- assisted tryptic digestion and identification of proteolytically resistant proteins. Anal. Biochem. 2008, 377, 259.
23. Z. Chen, A.M. Strack, Y. Chen, et al., Validation of human ApoB and ApoA1 immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research. J. Cardiovascular Transational Res. 2011, 4, 373.
24. J. Burchard, A.L. Jackson, V. Malkov, R.H.V. Needham, Y. Tan, S. Bartz, H. Dai, A. Sachs, P.S. Linsley,. MicroRNA-like off target transcript regulation by siRNAs is species specific. RNA 2009, 15, 308.